Case-Based Learning: Episodic Behavioral Changes With Normal Neurologic Examination

Abstract

Episodic behavioral change in a patient with a normal neurologic examination presents a substantial diagnostic challenge. Sudden or recurrent alterations in behavior, awareness, perception, affect, or executive function may reflect focal seizures, transient ischemia, migraine-related phenomena, toxic-metabolic disturbance, medication effects, sleep disorders, autoimmune encephalitis, functional neurologic symptoms, or primary psychiatric disease. A normal examination between episodes does not exclude clinically important cerebral dysfunction because many disorders are intermittent and leave no persistent focal deficit. This case-based review describes a structured approach to evaluation, emphasizing phenomenology, witness history, temporal pattern, precipitating factors, medication review, targeted laboratory testing, electroencephalography, neuroimaging, and appropriate specialty referral. Mechanism-based interpretation helps distinguish impaired awareness from behavioral disinhibition, psychosis, dissociation, delirium, and transient cognitive dysfunction. Early recognition of red flags, including new-onset episodes in later life, prolonged confusion, injury, fever, autonomic instability, or progressive cognitive decline, is essential. Management should address the underlying cause while reducing avoidable diagnostic delay, unnecessary psychiatric labeling, medication harm, and recurrent injury.

Introduction

Patients who experience brief, recurrent, and apparently unexplained behavioral changes are frequently encountered in emergency departments, primary care, neurology, psychiatry, geriatrics, and inpatient medicine. The presenting description may be vague: staring, inappropriate laughter, aggression, wandering, unusual speech, emotional lability, repetitive activity, suspiciousness, or sudden withdrawal. Between events, the individual may appear entirely well and demonstrate normal strength, sensation, coordination, language, and gait. This apparent normalization can falsely reassure clinicians and may lead to premature attribution to stress, personality, substance use, or psychiatric illness.

The central clinical task is to determine whether the episodes represent a disturbance of brain function, systemic physiology, behavior, or subjective experience. The history should define what happened before, during, and after each event; whether awareness was preserved; whether the patient could respond; the duration and frequency; associated motor, autonomic, sensory, or cognitive features; and the degree of post-event recovery. A witness account or recording obtained with appropriate consent may be more diagnostically valuable than the patient’s recollection, particularly when awareness or memory is impaired.

Epidemiology / Disease Burden

The precise prevalence of episodic behavioral change is difficult to quantify because it is a symptom rather than a single diagnosis. Transient altered awareness is common in epilepsy, syncope, migraine, sleep disorders, medication toxicity, and metabolic illness. Focal seizures may occur without convulsions and can manifest predominantly as behavioral arrest, confusion, fear, automatisms, dysphasia, or complex interaction with the environment. Older adults are particularly vulnerable to delirium, medication-related episodes, transient ischemic events, neurodegenerative disease, and nonconvulsive seizures. In younger patients, migraine, epilepsy, sleep-related disorders, substance exposure, functional neurologic symptoms, and autoimmune disease may be more prominent considerations.

The burden extends beyond diagnostic uncertainty. Recurrent episodes can cause falls, motor vehicle collisions, occupational risk, social isolation, loss of employment, family conflict, and inappropriate use of antipsychotic or antiseizure medication. Delayed recognition of seizures or encephalitis may permit status epilepticus, injury, cognitive decline, or permanent neurologic disability. Conversely, overdiagnosis of epilepsy or inflammatory disease can expose patients to unnecessary treatment and anxiety. A careful, probability-based evaluation is therefore both clinically and economically important.

Pathophysiology

Episodic behavioral alterations arise when transient dysfunction affects neural networks responsible for consciousness, attention, memory, emotional salience, language, inhibition, or executive control. Focal seizures involving mesial temporal, orbitofrontal, cingulate, or insular networks may produce fear, déjà vu, abdominal sensations, affective change, speech disturbance, or complex automatisms. Frontal lobe seizures can be brief, stereotyped, and motorically dramatic, while scalp electroencephalography may be normal if the electrical field is deep or rapidly propagated.

Transient cerebral hypoperfusion can impair attention and awareness, although classic syncope generally has a recognizable prodrome and brief recovery. Migraine mechanisms may involve cortical spreading depolarization, altered sensory processing, and brainstem or thalamocortical network dysfunction. Metabolic disturbances, including hypoglycemia, hypercapnia, electrolyte abnormalities, hepatic dysfunction, and hypoxia, interfere with neuronal energy production and synaptic transmission. Drugs may alter cholinergic, dopaminergic, GABAergic, serotonergic, or glutamatergic signaling, producing agitation, sedation, hallucinations, disinhibition, or fluctuating cognition.

Autoimmune encephalitis illustrates why a normal interictal examination cannot be considered definitive. Antibody-mediated synaptic or neuronal dysfunction may produce psychiatric symptoms, seizures, memory impairment, dyskinesias, sleep disruption, autonomic instability, or language disturbance before fixed neurologic signs emerge. Functional neurologic symptoms reflect altered attention, prediction, and agency within brain networks and are genuine clinical phenomena, but they should be diagnosed using positive clinical features rather than exclusion alone.

Risk Factors

Important risk factors include a previous seizure or brain injury, stroke, central nervous system infection, developmental neurologic disease, brain tumor, neurodegenerative disease, sleep deprivation, alcohol or sedative withdrawal, stimulant exposure, and recent medication changes. Drugs commonly associated with behavioral alteration include corticosteroids, dopaminergic agents, anticholinergic medications, benzodiazepines, opioids, sedative-hypnotics, some antiseizure medications, antidepressants, and medications with significant interaction potential. Polypharmacy and impaired renal or hepatic clearance increase risk.

Systemic vulnerability is also relevant. Advanced age, frailty, infection, renal failure, hepatic disease, endocrine disorders, nutritional deficiency, malignancy, immunosuppression, and recent hospitalization increase the likelihood of delirium or encephalopathy. Family history of epilepsy, migraine, autoimmune disease, or psychiatric illness may refine the differential but should not be used as a substitute for objective assessment. Sleep deprivation and psychosocial stress can precipitate epileptic and nonepileptic events alike, so their presence is supportive only when integrated with the complete clinical pattern.

Clinical Features

Features that increase suspicion for focal seizures include highly stereotyped episodes, abrupt onset and offset, behavioral arrest, impaired responsiveness, unilateral orofacial movements, automatisms, ictal fear, déjà vu, rising epigastric sensation, transient aphasia, or post-event confusion. Lateral tongue injury and urinary incontinence may support a seizure but are neither required nor specific. Episodes lasting seconds to a few minutes and recurring in a similar form are particularly important.

Delirium is characterized by an acute or subacute disturbance in attention and awareness with fluctuating severity and an underlying medical or toxic cause. It typically persists over hours or days rather than appearing only as highly stereotyped brief spells. Transient ischemic attack should be considered when episodes produce focal negative symptoms such as aphasia, visual loss, or unilateral weakness, although isolated behavioral change is less typical. Psychotic disorders usually cause symptoms that persist beyond a single brief event, whereas panic attacks often include intense fear, autonomic symptoms, hyperventilation, and preserved recall. Dissociative episodes may be prolonged and context-sensitive, but coexistence with epilepsy is possible.

Red flags requiring urgent evaluation include prolonged or repeated episodes without full recovery, fever, headache with meningismus, new seizures, severe autonomic disturbance, catatonia, rapidly progressive memory loss, new symptoms in an immunocompromised patient, pregnancy or postpartum status, significant trauma, anticoagulant use, hypoglycemia, toxic exposure, and a first episode in an older adult. Suicidal behavior, violence, inability to maintain airway protection, and unsafe wandering require immediate attention independent of the eventual diagnosis.

Diagnosis

Assessment begins with stabilization and bedside glucose measurement, followed by evaluation of oxygenation, temperature, circulation, intoxication, withdrawal, and infection. A detailed medication and substance history should include recent dose changes, missed doses, over-the-counter products, supplements, recreational drugs, and alcohol pattern. Basic investigations are guided by the presentation and may include complete blood count, electrolytes, renal and hepatic function, calcium, magnesium, inflammatory markers, urinalysis, toxicology testing, pregnancy testing when relevant, and selected endocrine or nutritional studies.

Electroencephalography is appropriate when seizures, nonconvulsive status epilepticus, or unexplained recurrent impaired awareness is suspected. A routine study may be normal and does not exclude epilepsy; prolonged ambulatory or video EEG can improve diagnostic yield by capturing typical events. Brain magnetic resonance imaging with an epilepsy-sensitive protocol is preferred when focal seizures, structural disease, or unexplained recurrent episodes are suspected. Computed tomography is useful for acute hemorrhage, trauma, mass effect, or when magnetic resonance imaging is unavailable.

Lumbar puncture should be considered when encephalitis, meningitis, inflammatory disease, or unexplained subacute cognitive and behavioral decline is suspected. Cerebrospinal fluid analysis may include cell count, protein, glucose, cultures, polymerase chain reaction testing, and selected autoimmune or paraneoplastic studies. Neuropsychological assessment can characterize interictal cognitive dysfunction, while collateral history and standardized delirium instruments improve recognition of fluctuating impairment. Psychiatric consultation is valuable, but a psychiatric formulation should follow an appropriate medical and neurologic evaluation when the presentation is new, atypical, or episodic.

Treatment & Management

Management is directed at the cause and immediate risk. Hypoglycemia, hypoxia, electrolyte abnormalities, infection, intoxication, and withdrawal require prompt correction. Suspected status epilepticus is a medical emergency requiring protocol-based benzodiazepine treatment and escalation to antiseizure therapy when indicated. For confirmed focal epilepsy, medication selection should reflect seizure type, comorbidities, reproductive considerations, renal and hepatic function, interaction profile, and patient preference. Adherence, sleep, alcohol moderation, and safety counseling are essential.

Medication-induced behavioral change is managed by identifying the offending agent, reducing dose when clinically safe, discontinuing it when appropriate, and monitoring for withdrawal or rebound effects. Delirium care prioritizes treatment of the precipitating illness, orientation, hearing and vision support, sleep preservation, mobilization, hydration, and avoidance of unnecessary restraints and anticholinergic drugs. Antipsychotics should not be used routinely for hypoactive or uncomplicated delirium and require caution in older adults and patients with parkinsonism or dementia.

Autoimmune encephalitis requires urgent specialist involvement and may require immunotherapy after appropriate infectious evaluation, often with corticosteroids, intravenous immunoglobulin, plasma exchange, or additional immunosuppression. Functional neurologic symptoms benefit from a clear, nonjudgmental explanation, identification of positive diagnostic features, coordinated neurology and mental health care, and rehabilitation focused on restoring function. Regardless of diagnosis, patients should receive individualized guidance regarding driving, occupational hazards, bathing, heights, and supervision during periods of uncertainty.

Recent Advances / Emerging Therapies

Recent advances emphasize prolonged digital monitoring, wearable physiologic sensors, home video capture, and machine-learning tools that may assist event detection. These technologies can support, but not replace, expert clinical interpretation because artifacts, false positives, and incomplete context remain important limitations. High-density EEG, advanced magnetic resonance imaging, positron emission tomography, and ictal single-photon emission computed tomography can improve localization in selected refractory cases.

In epilepsy, responsive neurostimulation, vagus nerve stimulation, deep brain stimulation, laser interstitial thermal therapy, and minimally invasive surgical approaches have expanded options for carefully selected drug-resistant patients. Precision treatment is increasingly informed by seizure networks, genetic testing, and comorbidity profiles. In autoimmune encephalitis, earlier antibody testing, improved intensive care, second-line immunotherapy, and structured cognitive rehabilitation may improve recovery, although evidence remains limited by disease rarity and heterogeneous study designs.

Guideline Recommendations

Evidence-based practice supports a structured first-event evaluation rather than relying on a normal examination or a single negative test. Clinicians should obtain a detailed witness history, assess provoking factors, perform targeted examination and laboratory testing, and arrange timely neurologic review when seizure or structural disease is plausible. Electroencephalography should be obtained as soon as practical when epilepsy is suspected, with prolonged monitoring when routine testing is nondiagnostic and events continue. Neuroimaging is recommended when the event is unexplained, focal, atypical, associated with persistent symptoms, or occurring in a patient with relevant structural risk.

Guideline-consistent care also requires reassessment. A provisional diagnosis should be revisited if episodes evolve, treatment fails, new cognitive or psychiatric symptoms appear, or collateral information changes the probability of competing diagnoses. Clinicians should avoid both premature psychiatric attribution and indiscriminate antiseizure treatment. Shared decision-making, documentation of uncertainty, safety planning, and communication with family or caregivers are central components of high-quality care.

Conclusion

Episodic behavioral changes with a normal neurologic examination should be approached as a potentially neurologic or systemic syndrome rather than as a diagnosis in itself. The normal interval examination reflects the intermittent nature of many disorders and cannot exclude focal seizures, encephalitis, toxic-metabolic dysfunction, migraine, or other clinically significant conditions. Careful phenomenology, collateral history, medication review, targeted testing, EEG when indicated, and appropriate imaging provide the foundation for accurate diagnosis. Early recognition of red flags and mechanism-based management can reduce injury, inappropriate treatment, diagnostic delay, and long-term disability. A balanced approach that remains alert to neurologic, medical, psychiatric, and functional explanations offers the greatest opportunity for safe and effective patient care.